WallStreetZenWallStreetZen

NASDAQ: FHTX
Foghorn Therapeutics Inc Stock Forecast, Predictions & Price Target

OverviewForecast
EarningsRevenueDividendOwnership

Analyst price target for FHTX

Based on 1 analyst offering 12 month price targets for Foghorn Therapeutics Inc

Min Forecast
$9.00+104.08%
Avg Forecast
$9.00+104.08%
Max Forecast
$9.00+104.08%

Should I buy or sell FHTX stock?

Based on 1 analyst offering ratings for Foghorn Therapeutics Inc.

Buy
Strong Buy
0 analysts 0%
Buy
1 analysts 100%
Hold
0 analysts 0%
Sell
0 analysts 0%
Strong Sell
0 analysts 0%
Although FHTX's forecast from analysts indicates a "Buy", our proven Zen Rating quant model rates FHTX as a "Hold". Stocks with a Zen Rating of Hold have had an average return of +7.53% per year. Learn More

Be the first to know when Wall Street analysts revise their FHTX stock forecasts and price targets.

FHTX stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
lockedlocked$00.00+00.00%2025-05-15

1 of 1

Forecast return on equity

Is FHTX forecast to generate an efficient return?

Insufficient data to display

Forecast return on assets

Is FHTX forecast to generate an efficient return on assets?

Company
-17.01%
Industry
106.32%
FHTX is forecast to generate... subscribe to Premium to read more.
Forecast Return on Assets vs Industry Forecast

FHTX earnings per share forecast

What is FHTX's earnings per share in the next 3 years based on estimates from 9 analysts?

Avg 1 year Forecast
-$1.21
Avg 2 year Forecast
-$1.14
Avg 3 year Forecast
-$1.21

FHTX revenue forecast

What is FHTX's revenue in the next 3 years based on estimates from 9 analysts?

Avg 1 year Forecast
$32.2M+33.17%
Avg 2 year Forecast
$36.9M+52.84%
Avg 3 year Forecast
$47.4M+96.21%
FHTX's revenue is forecast to... subscribe to Premium to read more.
Forecast High Revenue Growth Forecast

FHTX revenue growth forecast

How is FHTX forecast to perform vs Biotechnology companies and vs the US market?

Company
24.34%
Industry
106.08%
Market
24.86%
FHTX's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Industry Forecast
FHTX's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Market Forecast

FHTX vs Biotech Stocks

TickerPricePrice TargetUp/downsideConsensus
FHTX$4.41$9.00+104.08%Buy
IMRX$6.87$17.20+150.36%Buy
CLLS$3.45$8.00+131.88%Strong Buy
ZURA$3.84$11.25+192.97%Buy
ABEO$4.81$20.00+315.80%Strong Buy
View Top Biotech Stocks

Foghorn Therapeutics Stock Forecast FAQ

Is Foghorn Therapeutics Stock a good buy in 2025, according to Wall Street analysts?

The consensus among 1 Wall Street analyst covering (NASDAQ: FHTX) stock is to Buy FHTX stock.

Out of 1 analyst, 0 (0%) are recommending FHTX as a Strong Buy, 1 (100%) are recommending FHTX as a Buy, 0 (0%) are recommending FHTX as a Hold, 0 (0%) are recommending FHTX as a Sell, and 0 (0%) are recommending FHTX as a Strong Sell.

If you're new to stock investing, here's how to buy Foghorn Therapeutics stock.

What is FHTX's earnings growth forecast for 2025-2027?

(NASDAQ: FHTX) Foghorn Therapeutics's forecast annual earnings growth rate of N/A is not forecast to beat the US Biotechnology industry's average forecast earnings growth rate of 37.26%, and while it is not forecast to beat the US market's average forecast earnings growth rate of 41%.

Foghorn Therapeutics's earnings in 2025 is -$75,395,000.On average, 9 Wall Street analysts forecast FHTX's earnings for 2025 to be -$68,616,076, with the lowest FHTX earnings forecast at -$81,437,073, and the highest FHTX earnings forecast at -$58,169,338. On average, 9 Wall Street analysts forecast FHTX's earnings for 2026 to be -$64,579,837, with the lowest FHTX earnings forecast at -$95,286,916, and the highest FHTX earnings forecast at -$38,581,704.

In 2027, FHTX is forecast to generate -$68,372,998 in earnings, with the lowest earnings forecast at -$103,596,821 and the highest earnings forecast at -$30,271,798.

What is FHTX's revenue growth forecast for 2025-2027?

(NASDAQ: FHTX) Foghorn Therapeutics's forecast annual revenue growth rate of 24.34% is not forecast to beat the US Biotechnology industry's average forecast revenue growth rate of 106.08%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 24.86%.

Foghorn Therapeutics's revenue in 2025 is $24,173,000.On average, 9 Wall Street analysts forecast FHTX's revenue for 2025 to be $1,819,756,232, with the lowest FHTX revenue forecast at $1,301,885,186, and the highest FHTX revenue forecast at $2,285,732,767. On average, 9 Wall Street analysts forecast FHTX's revenue for 2026 to be $2,088,556,235, with the lowest FHTX revenue forecast at $0, and the highest FHTX revenue forecast at $3,561,388,047.

In 2027, FHTX is forecast to generate $2,681,159,900 in revenue, with the lowest revenue forecast at $1,107,987,392 and the highest revenue forecast at $3,632,615,808.

What is FHTX's forecast return on assets (ROA) for 2025-2028?

(NASDAQ: FHTX) forecast ROA is -17.01%, which is lower than the forecast US Biotechnology industry average of 106.32%.

What is FHTX's Price Target?

According to 1 Wall Street analyst that have issued a 1 year FHTX price target, the average FHTX price target is $9.00, with the highest FHTX stock price forecast at $9.00 and the lowest FHTX stock price forecast at $9.00.

The Wall Street analyst predicted that Foghorn Therapeutics's share price could reach $9.00 by May 15, 2026. The average Foghorn Therapeutics stock price prediction forecasts a potential upside of 104.08% from the current FHTX share price of $4.41.

What is FHTX's Earnings Per Share (EPS) forecast for 2025-2027?

(NASDAQ: FHTX) Foghorn Therapeutics's current Earnings Per Share (EPS) is -$1.19. On average, analysts forecast that FHTX's EPS will be -$1.21 for 2025, with the lowest EPS forecast at -$1.44, and the highest EPS forecast at -$1.03. On average, analysts forecast that FHTX's EPS will be -$1.14 for 2026, with the lowest EPS forecast at -$1.69, and the highest EPS forecast at -$0.68. In 2027, FHTX's EPS is forecast to hit -$1.21 (min: -$1.83, max: -$0.54).

What is FHTX's forecast return on equity (ROE) for 2025-2028?

(NASDAQ: FHTX) forecast ROE is N/A, which is considered weak.
©2025 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.